Alva Review-Courier -

J&J bolts higher after verdict in Oklahoma opioid case


August 28, 2019

Johnson & Johnson investors exhaled in relief Tuesday, pushing up the company's shares after an Oklahoma judge imposed a $572 million verdict for the health care giant's role in the nation's opioid crisis.

During the seven week trial, state prosecutors who sought up to $17 billion described J&J as a "kingpin" in an epidemic that's killed more than 400,000 Americans since 2000.

The monetary award announced Monday, and J&J's vow to appeal, reassured investors — at least for now.

"The risk of a loss was already baked into the stock price," noted Erik Gordon, an analyst and professor at Unive...

For access to this article please sign in or subscribe.


Reader Comments(0)


Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020